{"id":31598,"date":"2022-09-15T08:47:12","date_gmt":"2022-09-15T13:47:12","guid":{"rendered":"https:\/\/saluddigital.com\/?p=31598"},"modified":"2025-10-20T11:08:57","modified_gmt":"2025-10-20T17:08:57","slug":"microsoft-y-farmaceutica-colaboran-para-acelerar-descubrimiento-y-desarrollo-de-medicamentos-a-traves-de-ia","status":"publish","type":"post","link":"https:\/\/saluddigital.com\/en\/big-data\/microsoft-y-farmaceutica-colaboran-para-acelerar-descubrimiento-y-desarrollo-de-medicamentos-a-traves-de-ia\/","title":{"rendered":"Microsoft and pharmaceutical collaborate to accelerate drug discovery and development through AI"},"content":{"rendered":"
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Artificial Intelligence (AI) has become one of the new tools for the discovery and development of drugs and therapies.<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The pharmaceutical company Novo Nordisk and Microsoft have established a new strategic collaboration agreement that seeks to enhance Microsoft's computing services, cloud-based technology and Artificial Intelligence (AI) and the development and capacity of data science for the discovery of new Novo Nordisk medicines. Microsoft will provide AI technology and the expertise of its specialists, who will work with data scientists from the pharmaceutical company.<\/p>

\u201cWe are very excited about this new partnership that allows us to work closely with key Microsoft experts as we look to expand our AI and digital science capabilities,\u201d said Lars Fogh Iversen, senior vice president of Digital Science and Innovation at Novo Nordisk. . He also explained that they are on the ideal path to promote a faster and more scalable deployment of AI in drug discovery.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

On the other hand, Vijay Mital, Corporate Vice President of Architecture and AI Strategy. in the Technology and Research division of Microsoft, explained that to achieve these types of advances, AI must learn from all kinds of valuable information, which will require close collaboration between multiple disciplines.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The AI models developed through this collaboration will be applied in various cases. Even some have already started their execution and development. One of the models aims to automatically summarize and analyze information from literature, patents, scientific reports, discussion forums, to obtain valuable and scientifically relevant information.<\/p>

Likewise, another of the models seeks to develop new models that can predict a person's risk of developing atherosclerosis. Similarly, AI can be used to identify biomarkers of disease.<\/p>

Both parties expect the collaboration to last for several years, with new projects starting on an ongoing basis thanks to the adoption of a new approach that will feature an AI platform for training multiple sets of models.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t BIBLIOGRAPHY<\/a>\n\t\t\t\t\t<\/div>\n\n\t\t\t\t\t

NOVO NORDISK<\/strong><\/p>

https:\/\/www.novonordisk.com\/content\/nncorp\/global\/en\/news-and-media\/news-and-ir-materials\/news-details.html?id=134465<\/a><\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

La Inteligencia Artificial (IA), se ha convertido en una de las nuevas herramientas para el descubrimiento y desarrollo de medicamentos y terapias. La compa\u00f1\u00eda farmac\u00e9utica Novo Nordisk y Microsoft, han establecido un nuevo acuerdo de colaboraci\u00f3n estrat\u00e9gica que busca potenciar los servicios computacionales, tecnolog\u00eda basada en la nube e Inteligencia Artificial (IA) de Microsoft y el desarrollo y capacidad de ciencia de datos para el descubrimiento de nuevos medicamentos de Novo Nordisk. Microsoft proporcionar\u00e1 tecnolog\u00eda de IA y la experiencia de sus especialistas, quienes trabajaran con cient\u00edficos de datos de la farmac\u00e9utica. \u201cEstamos muy entusiasmados con esta nueva asociaci\u00f3n que nos permite trabajar en estrecha colaboraci\u00f3n con expertos clave de Microsoft a medida que buscamos expandir nuestras capacidades de inteligencia artificial y ciencia digital\u201d, dijo Lars Fogh Iversen, vicepresidente senior de Ciencia Digital e Innovaci\u00f3n en Novo Nordisk. Asimismo, explic\u00f3 que se encuentran en el camino ideal para promover un despliegue m\u00e1s r\u00e1pido y escalado de IA en el descubrimiento de f\u00e1rmacos. Por otra parte, Vijay Mital, vicepresidente corporativo de Arquitectura y Estrategia de IA. en la divisi\u00f3n de Tecnolog\u00eda e Investigaci\u00f3n de Microsoft, explic\u00f3 que para alcanzar este tipo de avances la IA debe aprender de todo tipo de informaci\u00f3n valiosa, por lo que ser\u00e1 necesario la colaboraci\u00f3n estrecha entre m\u00faltiples disciplinas. Los modelos de IA desarrollados a trav\u00e9s de esta colaboraci\u00f3n, ser\u00e1n aplicados en diversos casos. Incluso algunos ya han comenzado su ejecuci\u00f3n y desarrollo. Uno de los modelos tiene como objetivo resumir y analizar de manera automatizada la informaci\u00f3n de literatura, patentes, informes cient\u00edficos, foros de discusi\u00f3n, para obtener informaci\u00f3n valiosa y cient\u00edficamente relevante. Asimismo, otro de los modelos busca el desarrollo de nuevos modelos que logren predecir el riesgo de una persona de desarrollar aterosclerosis. De igual forma la IA puede utilizarse para la identificaci\u00f3n de biomarcadores de la enfermedad. Ambas partes contemplan que la colaboraci\u00f3n dure varios a\u00f1os y que se inicien nuevos proyectos de forma continua gracias a la adopci\u00f3n de un nuevo enfoque que contar\u00e1 con una plataforma de IA para el entrenamiento de m\u00faltiples conjuntos de modelos. BIBLIOGRAF\u00cdA NOVO NORDISK https:\/\/www.novonordisk.com\/content\/nncorp\/global\/en\/news-and-media\/news-and-ir-materials\/news-details.html?id=134465<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[156,160],"tags":[145],"class_list":["post-31598","post","type-post","status-publish","format-standard","hentry","category-big-data","category-noticias","tag-noticias"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts\/31598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/comments?post=31598"}],"version-history":[{"count":0,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/posts\/31598\/revisions"}],"wp:attachment":[{"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/media?parent=31598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/categories?post=31598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/saluddigital.com\/en\/wp-json\/wp\/v2\/tags?post=31598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}